NCT07270783

Healthy Volunteer Study

A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of D-2570 Tablets in Healthy Subjects

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: InventisBio Co., Ltd · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Double Blinded Healthy Volunteer study evaluating D-2570 against placebo in various doses.

Detailed description

Double blind study evaluating the safety, tolerability and PK data of D-2570/placebo in healthy volunteers.

Conditions

• Healthy Volunteer

Interventions

Type	Name	Description
DRUG	D-2570	D-2570
DRUG	Placebo	Placebo

Timeline

• Start date: 2025-12-04
• Primary completion: 2026-04-01
• Completion: 2026-06-01
• First posted: 2025-12-08
• Last updated: 2025-12-15

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study